EPILEX CHRONO 300 (H)

Main information

  • Trade name:
  • EPILEX CHRONO 300 (H) 15
  • Composition:
  • 15
  • Medicine domain:
  • Humans
  • Medicine type:
  • Allopathic drug

Documents

Localization

  • Available in:
  • EPILEX CHRONO 300 (H) 15
    India
  • Language:
  • English

Other information

Status

  • Source:
  • Central Drugs Standard Control Organization
  • Last update:
  • 09-08-2016

23-3-2018

King Arthur Flour Company, Inc. Voluntarily Recalls Organic Coconut Flour (16 Oz.) Because of Possible Health Risk

King Arthur Flour Company, Inc. Voluntarily Recalls Organic Coconut Flour (16 Oz.) Because of Possible Health Risk

King Arthur Flour Company is voluntarily recalling a limited quantity (6,300 cases) of Organic Coconut Flour (16 oz.), after testing revealed the presence of Salmonella in 1 pouch of Organic Coconut Flour (16 oz.).

FDA - U.S. Food and Drug Administration

26-12-2017

Auromedics Pharma LLC Issues Voluntary Nationwide Recall of Linezolid Injection 600mg/300ml, due to Presence White Particulate Matter that has been Identified as Mold

Auromedics Pharma LLC Issues Voluntary Nationwide Recall of Linezolid Injection 600mg/300ml, due to Presence White Particulate Matter that has been Identified as Mold

AuroMedics Pharma LLC is voluntarily recalling one lot of Linezolid Injection 600mg/300mL flexible bags, NDC 55150 -242 -51 batch CLZ160007 expiration August 2018 to the hospital level. This batch was distributed May 15 through August 14, 2017. The product was found to contain white particulate matter that has been identified as mold. This problem was discovered as a result of a product complaint in which the contents of one flexible bag from one batch CLZ160007 was found to contain white particulate mat...

FDA - U.S. Food and Drug Administration

26-12-2017

Linezolid Injection by Auromedics Pharma: Voluntary Recall 600mg/300mL flexible bags- Due to Presence White Particle Matter That Has Been Identified as Mold

Linezolid Injection by Auromedics Pharma: Voluntary Recall 600mg/300mL flexible bags- Due to Presence White Particle Matter That Has Been Identified as Mold

AuroMedics Pharma is voluntarily recalling one lot of Linezolid Injection 600mg/300mL flexible bags, NDC 55150 -242 -51 batch CLZ160007 expiration August 2018 to the hospital level. This batch was distributed May 15 through August 14, 2017. The product was found to contain white particulate matter that has been identified as mold.

FDA - U.S. Food and Drug Administration

11-9-2017

FDA Animal Drug Safety Communication:  Micotil 300 User Safety Alert

FDA Animal Drug Safety Communication: Micotil 300 User Safety Alert

The U.S. Food and Drug Administration is alerting cattle and sheep owners, farmworkers, veterinarians, physicians, emergency medical technicians, and other health care providers about the potential hazards to people exposed to the animal drug Micotil 300 (tilmicosin).

FDA - U.S. Food and Drug Administration

10-8-2017

International Laboratories, LLC Issues Voluntary Nationwide Recall of One (1) Lot of Pravastatin Sodium Tablets USP, 40mg Packaged in Bottles of 30 Tablets Due to Mislabeling NDC # 54458-925-16; Lot # 115698A

International Laboratories, LLC Issues Voluntary Nationwide Recall of One (1) Lot of Pravastatin Sodium Tablets USP, 40mg Packaged in Bottles of 30 Tablets Due to Mislabeling NDC # 54458-925-16; Lot # 115698A

International Laboratories, LLC is voluntarily recalling one (1) Lot of Pravastatin Sodium Tablets USP 40 mg packaged in bottles of 30 tablets, to the consumer level due to mislabeling. The product is labeled as Pravastatin Sodium Tablets USP 40 mg but contained Bupropion Hydrochloride XL 300 mg tablets.

FDA - U.S. Food and Drug Administration

17-7-2017



Out-of-Stock – Staloral 300 Birke/Staloral 300 3 Bäume, sublinguale Lösungen

Out-of-Stock – Staloral 300 Birke/Staloral 300 3 Bäume, sublinguale Lösungen

Befristete Bewilligung zum Vertrieb in deutscher Aufmachung.

Swissmedic - Swiss Agency for Therapeutic Products

13-6-2017

Annual report 2016 - Clinical trials of medicines

Annual report 2016 - Clinical trials of medicines

LLast year, the Danish Medicines Agency received 286 clinical trial applications. This is a small decline compared to 2015. However, the number of clinical trial applications has remained stable at around 300 applications per year since 2013.

Danish Medicines Agency

13-6-2017

 Annual report 2016 - Clinical trials of medicines

Annual report 2016 - Clinical trials of medicines

Last year, the Danish Medicines Agency received 286 clinical trial applications. This is a small decline compared to 2015. However, the number of clinical trial applications has remained stable at around 300 applications per year since 2013. ”We saw an increase in the number of planned trial subjects in 2016 of around 3,000 on Danish sites for trials authorised in 2016. Despite the fall in the number of clinical trial applications in 2016, we saw an increase of 16% in the number of planned trial subject...

Danish Medicines Agency

6-4-2017

More batches of EpiPen® are withdrawn

More batches of EpiPen® are withdrawn

MEDA has decided to withdraw four more batches of EpiPen®. The withdrawal concerns two batches of EpiPen® 300 micrograms/dose and two batches of EpiPen® Jr 150 micrograms/dose. The latter is used for acute hypersensitivity reactions in children. The reason for the withdrawal is that there is a risk that the auto-injector does not work.

Danish Medicines Agency

17-3-2017

Withdrawal of a batch of EpiPen® 300 micrograms

Withdrawal of a batch of EpiPen® 300 micrograms

MEDA recalls a batch of the adrenaline product EpiPen® 300 micrograms/dose, which is used for sudden allergic reactions. There is a risk that the auto-injector does not work. The withdrawal concerns product number 578818 with batch number: 5FA665B and expiry date 03/2017.

Danish Medicines Agency

21-2-2017

Takeda Pharma A/S recalls batch of Pamol® in packs of 300 film-coated tablets

Takeda Pharma A/S recalls batch of Pamol® in packs of 300 film-coated tablets

Takeda Pharma A/S recalls a batch of Pamol® in packs of 300 film-coated tablets after the discovery of Ibumetin 600 mg containing ibuprofen in some packs. Both types of medicine are used for the treatment of mild pain, but they work in different ways and may cause different adverse reactions.

Danish Medicines Agency

23-2-2018

VITA-JEC ESSENTIAL E-300 (Tocopherol) Injection [Aspen Veterinary Resources, Ltd]

VITA-JEC ESSENTIAL E-300 (Tocopherol) Injection [Aspen Veterinary Resources, Ltd]

Updated Date: Feb 23, 2018 EST

US - DailyMed

19-1-2018

ADHD Prescriptions Skyrocket Among Young Women

ADHD Prescriptions Skyrocket Among Young Women

The number of reproductive-age women in the United States who receive prescription medications for attention-deficit/hyperactivity disorder (ADHD) jumped more than 300% from 2003 to 2015, according to data released today by the Centers for Disease Control and Prevention (CDC).

US - RxList

19-1-2018

LINCOMED 300 (Lincomycin) Injection [Bimeda Inc., Division Of Cross Vetpharm Group]

LINCOMED 300 (Lincomycin) Injection [Bimeda Inc., Division Of Cross Vetpharm Group]

Updated Date: Jan 19, 2018 EST

US - DailyMed

10-1-2018

LINCOMYCIN 300 (Lincomycin) Injection [Vedco, Inc.]

LINCOMYCIN 300 (Lincomycin) Injection [Vedco, Inc.]

Updated Date: Jan 10, 2018 EST

US - DailyMed

14-12-2017

ANTI-AGING FOUNDATION SPF 15 SHADE 300 (Octinoxate) Emulsion [La Prairie, Inc.]

ANTI-AGING FOUNDATION SPF 15 SHADE 300 (Octinoxate) Emulsion [La Prairie, Inc.]

Updated Date: Dec 14, 2017 EST

US - DailyMed

22-11-2017

VITAMIN E-300 (Tocopherol) Injection [Agri Laboratories, Ltd.]

VITAMIN E-300 (Tocopherol) Injection [Agri Laboratories, Ltd.]

Updated Date: Nov 22, 2017 EST

US - DailyMed

22-9-2017

ARTHROCEN 300 MG (Avocado/Soy Unsaponifiables) Capsule [Pharmin USA, LLC]

ARTHROCEN 300 MG (Avocado/Soy Unsaponifiables) Capsule [Pharmin USA, LLC]

Updated Date: Sep 22, 2017 EST

US - DailyMed

10-8-2017

LINCOBAC 300 (Lincomycin) Injection [MWI/VetOne]

LINCOBAC 300 (Lincomycin) Injection [MWI/VetOne]

Updated Date: Aug 10, 2017 EST

US - DailyMed

26-4-2017

Scientific guideline:  Draft guideline on Guideline on core summary of product characteristics (SmPC) and package leaflet for iopamidol 300, draft: consultation open

Scientific guideline: Draft guideline on Guideline on core summary of product characteristics (SmPC) and package leaflet for iopamidol 300, draft: consultation open

This document describes the information to be included in the summary of product characteristics and package leaflet for iopamidol 300.

Europe - EMA - European Medicines Agency